Amlodipine Besylate And Benazepril Hydrochloride Capsule
Product Images NDC 71335-3125

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Benazepril Hydrochloride (NDC 71335-3125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (53566d4f Ff40 4815 B922 3416cde56fb1 01)

FDA Label Image

Image (53566d4f Ff40 4815 B922 3416cde56fb1 02)

FDA Label Image

Image (Aada4cd5 Cadb 42a9 8b24 Fcac5018df9e 362 1)

FDA Label Image

Image (Aada4cd5 Cadb 42a9 8b24 Fcac5018df9e 382 1)

FDA Label Image

Label (Lbl713353125)

Label (Lbl713353125)
This text appears to be a description of a medication package insert containing Amlodipine and Benazepril capsules. The capsules are mentioned to contain Amlodipine 10 mg (as amlodipine besylate USP) and Benazepril HCI USP 20 mg. The instructions advise storing the capsules at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Protection from moisture is recommended. The capsules are to be dispensed in a tight container and caution is advised to keep them out of the reach of children. For more detailed prescribing information, a QR code is provided on the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.